A product of growth arrest-specific gene 6 modulates scavenger receptor expression in human vascular smooth muscle cells. 1999

K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
First Department of internal Medicine, Kagawa Medical University, Kagawa, Japan. mkoji@kms.ac.jp

Although Gas6 is identified as a growth factor for vascular smooth muscle cells (VSMCs), its roles in these cells have not been clearly elucidated. To examine the role of Gas6 in atherosclerosis, we examined the effects of Gas6 on scavenger receptor family expression in VSMCs. Scavenger receptor class A, one of the scavenger receptor family members, was upregulated in VSMCs by Gas6. Furthermore, the atherogenic lipoprotein, oxidized LDL, induced Gas6 production in these cells. These results indicate that Gas6 plays an important role in foam cell formation in human VSMCs.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D011971 Receptors, Immunologic Cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells. Although these receptors were first identified in the immune system, many have important functions elsewhere. Immunologic Receptors,Immunologic Receptor,Immunological Receptors,Receptor, Immunologic,Receptors, Immunological
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions

Related Publications

K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
November 2000, Electrophoresis,
K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
May 1996, FEBS letters,
K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
November 2007, American journal of physiology. Renal physiology,
K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
March 2008, British journal of cancer,
K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
November 2014, Molecular pharmacology,
K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
January 2010, Journal of vascular research,
K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
November 1996, The Journal of clinical investigation,
K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
June 2005, Clinical science (London, England : 1979),
K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
February 1996, European journal of pharmacology,
K Murao, and H Imachi, and Y Sayo, and H Hosokawa, and M Sato, and T Ishida, and T Nakano, and T Kodama, and Y Sasaguri, and J Takahara
June 1992, The Journal of biological chemistry,
Copied contents to your clipboard!